Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Jul 24;4(4):e00127-19.
doi: 10.1128/mSphere.00127-19.

Different Biological Activities of Specific Interferon Alpha Subtypes

Affiliations
Comment

Different Biological Activities of Specific Interferon Alpha Subtypes

Kim J Hasenkrug et al. mSphere. .
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Rusinova I, Forster S, Yu S, Kannan A, Masse M, Cumming H, Chapman R, Hertzog PJ. 2013. Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res 41:D1040–D1046. doi:10.1093/nar/gks1215. - DOI - PMC - PubMed
    1. Schlaepfer E, Fahrny A, Gruenbach M, Kuster SP, Simon V, Schreiber G, Speck RF. 2019. Dose-dependent differences in HIV inhibition by different interferon alpha subtypes while having overall similar biologic effects. mSphere 4:e00637-18. doi:10.1128/mSphere.00637-18. - DOI - PMC - PubMed
    1. Lavender KJ, Gibbert K, Peterson KE, Van Dis E, Francois S, Woods T, Messer RJ, Gawanbacht A, Muller JA, Munch J, Phillips K, Race B, Harper MS, Guo K, Lee EJ, Trilling M, Hengel H, Piehler J, Verheyen J, Wilson CC, Santiago ML, Hasenkrug KJ, Dittmer U. 2016. Interferon alpha subtype-specific suppression of HIV-1 infection in vivo. J Virol 90:6001–6013. doi:10.1128/JVI.00451-16. - DOI - PMC - PubMed
    1. Robinson CJ. 1999. Bioassays for growth factors. Dev Biol Stand 97:21–27. - PubMed
    1. Daud A, Soon C, Dummer R, Eggermont AM, Hwu WJ, Grob JJ, Garbe C, Hauschild A. 2012. Management of pegylated interferon alpha toxicity in adjuvant therapy of melanoma. Expert Opin Biol Ther 12:1087–1099. doi:10.1517/14712598.2012.694421. - DOI - PubMed